<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Antibiotics (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Antibiotics (Basel)</journal-id><journal-id journal-id-type="publisher-id">antibiotics</journal-id><journal-title-group><journal-title>Antibiotics</journal-title></journal-title-group><issn pub-type="epub">2079-6382</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.3390/antibiotics9050247</article-id><article-id pub-id-type="publisher-id">antibiotics-09-00247</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>GC-MS Profile and Enhancement of Antibiotic Activity by the Essential Oil of <italic>Ocotea odor&#x000ed;fera</italic> and Safrole: Inhibition of <italic>Staphylococcus aureus</italic> Efflux Pumps</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7463-5648</contrib-id><name><surname>Almeida</surname><given-names>Ray S.</given-names></name><xref ref-type="aff" rid="af1-antibiotics-09-00247">1</xref></contrib><contrib contrib-type="author"><name><surname>Freitas</surname><given-names>Priscilla R.</given-names></name><xref ref-type="aff" rid="af1-antibiotics-09-00247">1</xref></contrib><contrib contrib-type="author"><name><surname>Ara&#x000fa;jo</surname><given-names>Ana Carolina J.</given-names></name><xref ref-type="aff" rid="af1-antibiotics-09-00247">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1065-9581</contrib-id><name><surname>Alencar Menezes</surname><given-names>Irwin R.</given-names></name><xref ref-type="aff" rid="af1-antibiotics-09-00247">1</xref></contrib><contrib contrib-type="author"><name><surname>Santos</surname><given-names>Eduardo L.</given-names></name><xref ref-type="aff" rid="af1-antibiotics-09-00247">1</xref></contrib><contrib contrib-type="author"><name><surname>Tintino</surname><given-names>Saulo R.</given-names></name><xref ref-type="aff" rid="af1-antibiotics-09-00247">1</xref></contrib><contrib contrib-type="author"><name><surname>Moura</surname><given-names>Talysson F.</given-names></name><xref ref-type="aff" rid="af1-antibiotics-09-00247">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3126-6509</contrib-id><name><surname>Filho</surname><given-names>Jaime R.</given-names></name><xref ref-type="aff" rid="af2-antibiotics-09-00247">2</xref></contrib><contrib contrib-type="author"><name><surname>Ferreira</surname><given-names>Vit&#x000f3;ria A.</given-names></name><xref ref-type="aff" rid="af3-antibiotics-09-00247">3</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Ana Cristina A.</given-names></name><xref ref-type="aff" rid="af4-antibiotics-09-00247">4</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Luiz E.</given-names></name><xref ref-type="aff" rid="af5-antibiotics-09-00247">5</xref></contrib><contrib contrib-type="author"><name><surname>do Amaral</surname><given-names>Wanderlei</given-names></name><xref ref-type="aff" rid="af5-antibiotics-09-00247">5</xref></contrib><contrib contrib-type="author"><name><surname>Deschamps</surname><given-names>C&#x000ed;cero</given-names></name><xref ref-type="aff" rid="af6-antibiotics-09-00247">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5063-1236</contrib-id><name><surname>Iriti</surname><given-names>Marcello</given-names></name><xref ref-type="aff" rid="af7-antibiotics-09-00247">7</xref><xref rid="c1-antibiotics-09-00247" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Melo Coutinho</surname><given-names>Henrique D.</given-names></name><xref ref-type="aff" rid="af1-antibiotics-09-00247">1</xref><xref rid="c1-antibiotics-09-00247" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-antibiotics-09-00247"><label>1</label>Department of Biological Chemistry, Regional University of Cariri-URCA, Crato 63105-000, Brazil; <email>rayalmeidasilva2306@gmail.com</email> (R.S.A.); <email>priscilla.r.freitas@hotmail.com</email> (P.R.F.); <email>caroljustino@outlook.com</email> (A.C.J.A.); <email>Irwin.alencar@urca.br</email> (I.R.A.M.); <email>Eduardo.l.santos@kroton.com.br</email> (E.L.S.); <email>saulo.tintino@urca.br</email> (S.R.T.); <email>talysson97f.moura@gmail.com</email> (T.F.M.)</aff><aff id="af2-antibiotics-09-00247"><label>2</label>Gon&#x000e7;alo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador 40296-710, Brazil; <email>jaime.ribeiro@fiocruz.br</email></aff><aff id="af3-antibiotics-09-00247"><label>3</label>Department of Biomedicine, Christus University Center-Unichristus, Fortaleza 60190-060, Brazil; <email>vitoriaferreira057@outlook.com</email></aff><aff id="af4-antibiotics-09-00247"><label>4</label>Department of Biomedicine, Maur&#x000ed;cio de Nassau College-UNINASSAU, Petrolina 58401-115, Brazil; <email>011800513@prof.uninassau.edu.br</email></aff><aff id="af5-antibiotics-09-00247"><label>5</label>Post Graduate Program in Sustainable Territorial Development, Federal University of Paran&#x000e1;&#x02013;UFPR, Matinhos 59950-000, Brazil; <email>luizeverson@ufpr.br</email> (L.E.S.); <email>wdoamaral@ufpr.br</email> (W.d.A.)</aff><aff id="af6-antibiotics-09-00247"><label>6</label>Department of Chemistry, Post Graduate Program in Agronomy, Federal University of Paran&#x000e1;-UFPR, Curitiba 80011970, Brazil; <email>cicero@ufpr.br</email></aff><aff id="af7-antibiotics-09-00247"><label>7</label>Department of Agricultural and Environmental Sciences, Milan State University, via G. Celoria 2, 20133 Milan, Italy</aff><author-notes><corresp id="c1-antibiotics-09-00247"><label>*</label>Correspondence: <email>marcello.iriti@unimi.it</email> (M.I.); <email>hdmcoutinho@urca.br</email> (H.D.M.C.)</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>5</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2020</year></pub-date><volume>9</volume><issue>5</issue><elocation-id>247</elocation-id><history><date date-type="received"><day>21</day><month>4</month><year>2020</year></date><date date-type="accepted"><day>05</day><month>5</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Considering the evidence that essential oils, as well as safrole, could modulate bacterial growth in different resistant strains, this study aims to characterize the phytochemical profile and evaluate the antibacterial and antibiotic-modulating properties of the essential oil <italic>Ocotea odor&#x000ed;fera</italic> (EOOO) and safrole against efflux pump (EP)-carrying strains. The EOOO was extracted by hydrodistillation, and the phytochemical analysis was performed by gas chromatography coupled to mass spectrometry (GC-MS). The antibacterial and antibiotic-modulating activities of the EOOO and safrole against resistant strains of <italic>Staphylococcus aureus, Escherichia coli</italic> and <italic>Pseudomonas aeruginosa</italic> were analyzed through the broth microdilution method. The EP-inhibiting potential of safrole in association with ethidium bromide or antibiotics was evaluated using the <italic>S. aureus</italic> 1199B and K2068 strains, which carry genes encoding efflux proteins associated with antibiotic resistance to norfloxacin and ciprofloxacin, respectively. A reduction in the MIC of ethidium bromide or antibiotics was used as a parameter of EP inhibition. The phytochemical analysis identified 16 different compounds in the EOOO including safrole as the principal constituent. While the EOOO and safrole exerted clinically relevant antibacterial effects against <italic>S. aureus</italic> only, they potentiated the antibacterial activity of norfloxacin against all strains evaluated by our study. The ethidium bromide and antibiotic assays using the strains of <italic>S. aureus</italic> SA1119B and K2068, as well as molecular docking analysis, indicated that safrole inhibits the NorA and MepA efflux pumps in <italic>S. aureus.</italic> In conclusion, <italic>Ocotea odorifera</italic> and safrole presented promising antibacterial and antibiotic-enhancing properties, which should be explored in the development of drugs to combat antibacterial resistance, especially in strains bearing genes encoding efflux proteins.</p></abstract><kwd-group><kwd>ethidium bromide</kwd><kwd>bacterial resistance</kwd><kwd>biological activity</kwd><kwd>chemical composition</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-antibiotics-09-00247"><title>1. Introduction</title><p>Compounds generated by the secondary metabolism of plants constitute a large group of substances with significant structural and functional diversity, among which essential oils are notable bioactive compounds with antifungal, antiviral, antiprotozoal and antibacterial properties [<xref rid="B1-antibiotics-09-00247" ref-type="bibr">1</xref>,<xref rid="B2-antibiotics-09-00247" ref-type="bibr">2</xref>,<xref rid="B3-antibiotics-09-00247" ref-type="bibr">3</xref>,<xref rid="B4-antibiotics-09-00247" ref-type="bibr">4</xref>]. Essential oils are complex mixtures of volatile and aromatic compounds found in a great variety of plant species, acting in defense against infections, parasites, and other stress conditions [<xref rid="B5-antibiotics-09-00247" ref-type="bibr">5</xref>,<xref rid="B6-antibiotics-09-00247" ref-type="bibr">6</xref>]. In this context, terpenes, which comprise the largest class of natural products, have been identified as very potent bioactive compounds [<xref rid="B7-antibiotics-09-00247" ref-type="bibr">7</xref>]. Thymol and carvacrol are notable compounds with potent antimicrobial activities. These monoterpenes have been found as major constituents of essential oils obtained from a wide variety of aromatic plants [<xref rid="B8-antibiotics-09-00247" ref-type="bibr">8</xref>]. Accordingly, the essential oil of the leaves of Aloysia gratissima and Baccharis reticulata, which have 1,8-cineole, germacrene D, &#x003b1;-pinene, &#x003b2;-caryophyllene, and &#x003b2; -pinene as major constituents, demonstrated bactericidal activity against both Gram-positive (<italic>Staphylococcus aureus</italic> and <italic>Bacillus cereus</italic>) and Gram-negative (<italic>Escherichia coli</italic> and <italic>Pseudomonas aeruginosa</italic>) bacterial strains [<xref rid="B9-antibiotics-09-00247" ref-type="bibr">9</xref>,<xref rid="B10-antibiotics-09-00247" ref-type="bibr">10</xref>].</p><p><italic>Ocotea odor&#x000ed;fera</italic> (Lauraceae) is a plant popularly known as &#x0201c;sassafras&#x0201d;. This species, native to Brazil, is widely found in the Atlantic Forest where is used by the local communities in the treatment of malaria and rheumatism. In addition, due to its remarkable chemical constitution and abundance of essential oils, this plant has been used as a source of flavoring agents in the food industry [<xref rid="B11-antibiotics-09-00247" ref-type="bibr">11</xref>,<xref rid="B12-antibiotics-09-00247" ref-type="bibr">12</xref>,<xref rid="B13-antibiotics-09-00247" ref-type="bibr">13</xref>]. Previous research with the essential oil of <italic>O. odorifera</italic> (EOOO) has identified safrole (C<sub>10</sub>H<sub>10</sub>O<sub>2</sub>) as a major constituent, with unique chemical and pharmacological properties [<xref rid="B14-antibiotics-09-00247" ref-type="bibr">14</xref>,<xref rid="B15-antibiotics-09-00247" ref-type="bibr">15</xref>,<xref rid="B16-antibiotics-09-00247" ref-type="bibr">16</xref>]. Accordingly, safrole has been used in the production of fragrances and as a raw material in the synthesis of drugs and insecticides [<xref rid="B17-antibiotics-09-00247" ref-type="bibr">17</xref>]. While the effects of essential oils containing safrole against Gram-negative strains of <italic>Escherichia coli, Salmonella thyphimurium</italic>, and <italic>Pseudomonas aeruginosa</italic>, have been demonstrated previously, the antibacterial activity of this organic compound against <italic>Staphylococcus aureus</italic> strains remains to be characterized [<xref rid="B18-antibiotics-09-00247" ref-type="bibr">18</xref>,<xref rid="B19-antibiotics-09-00247" ref-type="bibr">19</xref>,<xref rid="B20-antibiotics-09-00247" ref-type="bibr">20</xref>].</p><p><italic>S. aureus</italic> is a Gram-positive bacterium with remarkable pathogenicity. Accordingly, resistance to antibiotics is currently a major worldwide public health problem [<xref rid="B21-antibiotics-09-00247" ref-type="bibr">21</xref>]. Resistant bacteria are characterized by the presence of natural or acquired mechanisms that confer survivability even in the presence of high concentrations of antibiotics [<xref rid="B22-antibiotics-09-00247" ref-type="bibr">22</xref>]. In this context, genetic modification of the binding site, enzymatic inactivation, and active transport by efflux pumps (EPs) are recognized as the principal mechanisms of resistance to antibiotics [<xref rid="B23-antibiotics-09-00247" ref-type="bibr">23</xref>]. Importantly, EPs were found to mediate antibiotic resistance in several strains of <italic>S. aureus</italic>. By actively transporting drugs to the extracellular medium, these transmembrane proteins reduce the intracellular concentrations of antibiotics, resulting in ineffective therapy [<xref rid="B24-antibiotics-09-00247" ref-type="bibr">24</xref>].</p><p>Aiming to discover new weapons to combat bacterial resistance, researchers have been dedicated to investigating the antibacterial and antibiotic-modulating properties of natural products. Therefore, considering the evidence that essential oils and safrole could modulate bacterial growth in different resistant strains, this study aims to characterize the phytochemical profile and evaluate the antibacterial and antibiotic-modulating properties of the essential oil of <italic>Ocotea odoriferas</italic> and safrole in EP-carrying strains.</p></sec><sec sec-type="results" id="sec2-antibiotics-09-00247"><title>2. Results</title><sec id="sec2dot1-antibiotics-09-00247"><title>2.1. Chemical Composition of the Essential Oil of Ocotea Odor&#x000ed;fera</title><p>The extraction of the EOOO by hydrodistillation presented a yield of 2.31%, considering the dry weight of the botanical material. Phytochemical analysis of the essential oil through gas chromatography coupled with mass spectrometry (GC-MS) identified 93.1% of the total constituents, revealing the presence of 16 different compounds, including safrole (77.9%), spathulenol (4.0%) and ortho-cymene (3.0%) as major constituents (<xref rid="antibiotics-09-00247-t001" ref-type="table">Table 1</xref>).</p></sec><sec id="sec2dot2-antibiotics-09-00247"><title>2.2. Antibacterial Activities of the EOOO and Safrole</title><p>The broth dilution method was used to determine the Minimum Inhibitory Concentration (MIC) of the essential oil of <italic>Ocotea odorifera</italic> and its major constituent safrole against multi-resistant strains of <italic>S. aureus</italic>, <italic>E. coli</italic> and <italic>P. aeruginosa</italic>. The antibacterial activity analysis revealed that both treatments presented MIC values above 1024 &#x003bc;g/mL against <italic>E. coli</italic> and <italic>P. aeruginosa</italic>, indicating that they exert clinically ineffective antibacterial activity against these strains. However, both treatments presented MIC values of 512 &#x003bc;g/mL against <italic>S. aureus</italic>, suggesting that <italic>O. odorifera</italic> and its major constituent safrole exert antibacterial effects against this Gram-positive strain (<xref rid="antibiotics-09-00247-t002" ref-type="table">Table 2</xref>).</p></sec><sec id="sec2dot3-antibiotics-09-00247"><title>2.3. Antibiotic-Potentiating Effects of the EOOO and Safrole</title><p>As the EOOO and safrole presented variable intrinsic antibacterial activity, this study analyzed the ability of these substances to modulate the antibacterial resistance to norfloxacin, a fluoroquinolone antibiotic. To this end, the MIC of this antibiotic was calculated after culturing the same bacterial strains in the presence or absence of the natural products at concentrations equivalent to their MIC &#x000f7; 8. As shown in <xref ref-type="fig" rid="antibiotics-09-00247-f001">Figure 1</xref>, The MIC values of norfloxacin against strains of <italic>S. aureus, P. aeruginosa</italic> and <italic>E. coli</italic> were significantly reduced by both EOOO and safrole, indicating that they present antibiotic-modulating effects against all investigated strains. Interestingly, while these treatments did not present direct antibacterial effects against <italic>P. aeruginosa</italic> and <italic>E. coli</italic>, they were found to modulate the antibacterial resistance to norfloxacin observed for the Gram-positive and Gram-negative strains evaluated by the present study.</p></sec><sec id="sec2dot4-antibiotics-09-00247"><title>2.4. Effects of Safrole on the S. aureus NorA and MepA Efflux Proteins</title><p>The ethidium bromide assay has been widely used to evaluate the potential action of drugs as EP inhibitors [<xref rid="B25-antibiotics-09-00247" ref-type="bibr">25</xref>]. Therefore, it was evaluated whether safrole could modulate bacterial resistance in the <italic>S. aureus</italic> 1199B and K2068 strains, which express the NorA and MepA EP, respectively. The association with subinhibitory concentrations of safrole or chlorpromazine (control drug) significantly reduced the MIC of ethidium bromide against both strains, indicating that safrole could act as an EP inhibitor in some <italic>S. aureus</italic> strains (<xref ref-type="fig" rid="antibiotics-09-00247-f002">Figure 2</xref>).</p><p>Following the promising effects demonstrated by safrole in the ethidium bromide test, the effects of this compound as a modulator of bacterial resistance in association with norfloxacin and ciprofloxacin was investigated. Of note, the 1199B and K2068 strains, respectively, bear resistance genes against each of these antibiotics. To this end, the MIC of this antibiotic was calculated after culturing the same bacterial strains in the presence or absence of the natural products at concentrations equivalent to their MIC &#x000f7; 8. As shown in <xref ref-type="fig" rid="antibiotics-09-00247-f003">Figure 3</xref>, the association with safrole or chlorpromazine (control) significantly reduced the MICs of both antibiotics, suggesting that the resistance to these drugs was, at least partially, reverted by safrole, which possibly inhibits the NorA and MepA-mediated efflux mechanisms in <italic>S. aureus.</italic></p></sec><sec id="sec2dot5-antibiotics-09-00247"><title>2.5. Molecular Docking and Analysis of Knteractions between Safrole and Efflux Proteins</title><p>The docking simulations determined the ligand-bound protein complexes with minimal energy and the best stability. The best-docked ligand conformations were saved in output clusters 0. The docking studies revealed that chlorpromazine and safrole presented the most favorable interaction energies (IE), which were positively correlated with their MIC values, inhibition constants (Ki) and size-independent ligand efficiency (SILE) for both NorA (<xref rid="antibiotics-09-00247-t003" ref-type="table">Table 3</xref>) and MepA (<xref rid="antibiotics-09-00247-t004" ref-type="table">Table 4</xref>) efflux proteins. Together, this data shows that safrole has a more favorable interaction with the MepA protein compared to NorA.</p><p><xref ref-type="fig" rid="antibiotics-09-00247-f004">Figure 4</xref> shows the chemical structures of safrole (<xref ref-type="fig" rid="antibiotics-09-00247-f004">Figure 4</xref>A) and chlorpromazine (<xref ref-type="fig" rid="antibiotics-09-00247-f004">Figure 4</xref>B) in the binding pockets of the NorA (<xref ref-type="fig" rid="antibiotics-09-00247-f004">Figure 4</xref>C) and MepA (<xref ref-type="fig" rid="antibiotics-09-00247-f004">Figure 4</xref>D) efflux pumps. Interaction maps were used to predict the participation of amino acid residues in the binding of chlorpromazine (<xref ref-type="fig" rid="antibiotics-09-00247-f004">Figure 4</xref>E,F) or safrole (<xref ref-type="fig" rid="antibiotics-09-00247-f004">Figure 4</xref>G,H) to these efflux pumps. The interaction maps show that chlorpromazine and safrole similarly interact with the MepA binding site through anchors with Glu287, Leu366, Met363, Met341 Pro286, Val283, Leu282, and Val334, as well as with the NorA binding site through Gly342, Val286, Ile258, Ala261, Ile341, Ala339, Leu325, and Phe283. The interactions between these amino acids and safrole are given at nonpolar and partially hydrophobic regions involving Van der Waals, &#x003c0;-Allyl, and Allyl interactions. On the other hand, the binding of chlorpromazine to the corresponding amino acids predominantly involves Van der Waals, &#x003c0;-Allyl, Allyl, carbon hydrogen bond, &#x003c0;-&#x003c0;, &#x003c0;-sigma, and &#x003c0;-sulfur interactions. These findings corroborate the evidence that safrole, as well as chlorpromazine, could act as efflux pump inhibitors in the <italic>S. aureus</italic> SA1119B and K2068 strains.</p></sec></sec><sec sec-type="discussion" id="sec3-antibiotics-09-00247"><title>3. Discussion</title><p>The discovery of penicillin represented an important milestone in the therapy of bacterial diseases and opened new perspectives for antibacterial drug development. Additionally, the introduction of the last generation of antibiotics has had a significant impact on public health, contributing to reduced morbidity and mortality rates caused by bacterial infections. However, the irrational use of this therapeutic classes has contributed to the selection of multidrug-resistant bacterial strains, against which conventional antibiotics may become ineffective. Therefore, the discovery of new antibiotics is crucially important to ensure the success of antibiotic therapy in future medicine [<xref rid="B26-antibiotics-09-00247" ref-type="bibr">26</xref>,<xref rid="B27-antibiotics-09-00247" ref-type="bibr">27</xref>,<xref rid="B28-antibiotics-09-00247" ref-type="bibr">28</xref>].</p><p>The present research investigated the antibacterial effects of the essential oil of <italic>O. odorifera</italic> and its major constituent safrole against multi-resistant strains. The phytochemical analysis identified 93.1% of the total constituents of the EOOO, revealing the presence of 16 different compounds, including safrole as a major constituent. This finding is corroborated by a previous study showing a similar composition, as well as the presence of safrole as the principal component of essential oil obtained from the leaves of the same species [<xref rid="B29-antibiotics-09-00247" ref-type="bibr">29</xref>]. According to Junior et al. [<xref rid="B30-antibiotics-09-00247" ref-type="bibr">30</xref>] and Lorenzi and Matos [<xref rid="B31-antibiotics-09-00247" ref-type="bibr">31</xref>], safrole is a bioactive compound widely used in the food, cosmetic, and pharmaceutical industries. In general, essential oils present significant yield, and their composition can vary depending on climatic and environmental factors, such as temperature, humidity, precipitation, soil, and time of collection. Additionally, the part of the plant used (leaves, bark, seeds or root), as well as the method of the extraction, may interfere with the composition of the essential oil of a given species [<xref rid="B15-antibiotics-09-00247" ref-type="bibr">15</xref>,<xref rid="B32-antibiotics-09-00247" ref-type="bibr">32</xref>,<xref rid="B33-antibiotics-09-00247" ref-type="bibr">33</xref>].</p><p>The antibacterial activity analysis revealed that while the essential oil of <italic>O. odorifera</italic> and safrole presented clinically ineffective antibacterial activity against <italic>E. coli</italic> and <italic>P. aeruginosa</italic>, they presented clinically relevant MIC values against <italic>S. aureus</italic>. The data obtained by this study suggest that safrole is, at least partially, responsible for the antibacterial effects of the EOOO. It is still suggested that both the oil and the isolated compound are more effective against Gram-positive strains, which may be justified by differences in the constitution of the membrane of Gram-positive and Gram-negative bacteria.</p><p>According to Nazzaro et al. [<xref rid="B34-antibiotics-09-00247" ref-type="bibr">34</xref>], Gram-negative bacteria are more resistant to the penetration of essential oils due to the presence of an outer layer of lipopolysaccharides. Accordingly, Betim et al. [<xref rid="B35-antibiotics-09-00247" ref-type="bibr">35</xref>], comparing the antibacterial activities of <italic>O. odor&#x000ed;fera</italic> and <italic>O. nutans</italic>, demonstrated that the essential oil of <italic>O. odor&#x000ed;fera</italic> presented more potent effects. In addition, they found that both essential oils were more effective against Gram-positive bacteria, corroborating the findings of the present research. On the other hand, a study by Damascemo et al. [<xref rid="B36-antibiotics-09-00247" ref-type="bibr">36</xref>] found clinically ineffective MIC values for the essential oil of <italic>O. bicolor</italic> against <italic>S. aureus, P. aeruginosa</italic>, and <italic>E. coli</italic>. Furthermore, Cansian et al. [<xref rid="B37-antibiotics-09-00247" ref-type="bibr">37</xref>] found that an essential oil obtained from <italic>O. odorifera</italic> was more efficient against Gram-negative bacteria. As discussed above, the chemical composition of a species may be significantly influenced by several environmental factors, which may affect the pharmacological effects of extracts, fractions, and essential oils.</p><p>Following the antibacterial activity analysis, this work investigated the ability of the EOOO and safrole ability to modulate the antibacterial resistance to norfloxacin, a fluoroquinolone antibiotic. The MIC values of norfloxacin against strains of <italic>S. aureus, P. aeruginosa</italic>, and <italic>E. coli</italic> were significantly reduced in the presence of a subinhibitory concentration of the EOOO and safrole (MIC &#x000f7; 8) indicating that both the oil and the isolated compound can modulate the antibacterial resistance to norfloxacin observed for the Gram-positive and Gram-negative strains evaluated by our study. Nevertheless, the isolated compound showed more potent antibiotic-enhancing activity against all strains, reducing the MIC of norfloxacin by up to 7 fold in comparison with the antibiotic alone. Studies have demonstrated that antibacterial resistance to norfloxacin is significantly mediated by the expression of efflux systems [<xref rid="B38-antibiotics-09-00247" ref-type="bibr">38</xref>]. Therefore, it is hypothesized that the antibiotic-enhancing effects shown by the EOOO and safrole might involve inhibition of efflux pumps.</p><p>Efflux pumps are membrane proteins that carry out the active transport of a wide range of molecules, removing potentially toxic substances from the intracellular medium. However, in the context of antibiotic therapy, the active transport of drugs by these proteins results in reduced intracellular concentrations and, consequently, failure in the therapeutic effect [<xref rid="B23-antibiotics-09-00247" ref-type="bibr">23</xref>]. Increasing evidence has demonstrated that efflux pumps are overexpressed in multiresistant bacterial strains, such as methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA). Thus, considering the notable role of efflux pumps on antibacterial resistance in <italic>S. aureus,</italic> we evaluated the potential involvement of EP inhibition on safrole-mediated antibiotic resistance modulation in the <italic>S. aureus</italic> 1199B and K2068 strains, which express the NorA and MepA EP, respectively. In the present study, the association with subinhibitory concentrations of safrole or chlorpromazine (control drug) significantly reduced the MIC of ethidium bromide against both strains. According to Tintino et al. [<xref rid="B39-antibiotics-09-00247" ref-type="bibr">39</xref>], when natural or synthetic compounds are tested against EP-bearing strains in association with ethidium bromide, a reduction in the MIC of this substance indicates that the tested compound also acts as an EP inhibitor. Thus, it is suggested that safrole could serve as an EP inhibitor in these <italic>S. aureus</italic> strains.</p><p>Accordingly, Oliveira-Tintino et al. [<xref rid="B40-antibiotics-09-00247" ref-type="bibr">40</xref>] reported that while the essential oil of <italic>Chenopodium ambrosioides</italic> significantly reduced the MIC of ethidium bromide against the 1199B strain, its principal constituent &#x003b1;-Terpinene presented no significant modulating effect, suggesting that other components of the <italic>C. ambrosioides</italic> oil could act as EP inhibitors. However, the molecular mechanisms associated with EP inhibition by essential oils, as well as their isolated components, remain to be fully characterized. Nevertheless, since ethidium bromide is used as a substrate by bacterial EP, it is hypothesized that these natural products could act by blocking the binding of the substrate to the pump. Additionally, it has been suggested that energy depletion, competition with ATP, and interference with the proton gradient are potential mechanisms associated with EP inhibition by natural or synthetic compounds [<xref rid="B41-antibiotics-09-00247" ref-type="bibr">41</xref>].</p><p>Considering the promising effects demonstrated by safrole in the efflux pump inhibition assay, it was evaluated whether safrole could modulate bacterial resistance <italic>S. aureus</italic> strains bearing resistance genes against norfloxacin and ciprofloxacin. The results of the present study demonstrated that safrole, as well as the EP inhibitor chlorpromazine (control), significantly reduced the MICs of both antibiotics, suggesting that the resistance to these drugs was, at least partially, reverted by safrole, which possibly inhibits the NorA- and MepA-mediated efflux mechanisms in <italic>S. aureus</italic> [<xref rid="B42-antibiotics-09-00247" ref-type="bibr">42</xref>,<xref rid="B43-antibiotics-09-00247" ref-type="bibr">43</xref>]. To confirm this hypothesis, molecular modeling and docking analysis were used to evaluate in silico, the potential interactions between safrole or chlorpromazine (control drug) and the NorA and MepA efflux pumps. The present findings suggest that safrole, as well as chlorpromazine, could act as efflux pump inhibitors in the <italic>S. aureus</italic> SA1119B and K2068 strains, and that safrole has a more favorable interaction with the MepA protein compared to NorA.</p><p>Previous studies suggest that chlorpromazine affects the membrane potassium flow in <italic>S. aureus</italic>. However, in multi-drug resistant strains, a significant inhibition is observed only at concentrations above 50 &#x000b5;M [<xref rid="B44-antibiotics-09-00247" ref-type="bibr">44</xref>]. Chlorpromazine is a typical antipsychotic drug acting as a dopamine antagonist. Curiously, studies have shown that this drug also acts as a strong inhibitor of the NorA efflux pump, and there is evidence that the interaction between this drug and the amino acid residues is favored by its hydrophobic properties and molecular dimension, corroborating the findings shown in the interaction map [<xref rid="B45-antibiotics-09-00247" ref-type="bibr">45</xref>].</p><p>Finally, structure-activity relationship (SAR) studies indicate that phenyl-ether groups significantly contribute to the interactions with the NorA and MepA EP in <italic>S. aureus</italic> [<xref rid="B46-antibiotics-09-00247" ref-type="bibr">46</xref>]. Additionally, accumulating evidence suggest that high lipophilicity facilitates the action of EP inhibitors on these proteins, corroborating the findings of the present research [<xref rid="B43-antibiotics-09-00247" ref-type="bibr">43</xref>].</p></sec><sec id="sec4-antibiotics-09-00247"><title>4. Materials and Methods</title><sec id="sec4dot1-antibiotics-09-00247"><title>4.1. Collection and Identification of the Botanic Material</title><p>The essential oil was extracted from terminal branches and inflorescences of plants (<xref ref-type="fig" rid="antibiotics-09-00247-f005">Figure 5</xref>) collected in a segment of Atlantic Forest in the State of Paran&#x000e1;, Southern Brazil, located at the following geographical coordinates: S 25&#x000b0; 19.862&#x02032; W 49&#x000b0; 48.338&#x02032;. The collection and transport of the plant samples were performed under the authorization of the Paran&#x000e1; Environmental Institute (registry number 284/11). A voucher specimen was prepared and registered at the Herbarium of &#x0201c;Faculdades Integradas Espirita&#x0201d; (HFIE) (registry number 9.000). Terminal branches and inflorescences were randomly collected from at least 10 individual plants and dried with an electric dryer (Gama Italy IQ perfetto 127V) at 40 &#x000b0;C for 24 h.</p></sec><sec id="sec4dot2-antibiotics-09-00247"><title>4.2. Essential Oil Extraction</title><p>The essential oil of <italic>O. odoriferous</italic> was extracted by hydrodistillation in a Clevenger type apparatus. Briefly, approximately 1 kg of the plant material was crushed and subjected to extraction with 2.5 L of distilled water at boiling temperature for 2 h. After extraction, the essential oil was combined with anhydrous sodium sulfate (Na<sub>2</sub>SO<sub>4</sub>) and stored under refrigeration (&#x02212;4 &#x000b0;C) for preservation [<xref rid="B47-antibiotics-09-00247" ref-type="bibr">47</xref>].</p></sec><sec id="sec4dot3-antibiotics-09-00247"><title>4.3. Calculation of Essential Oil Yield</title><p>The yield of the essential oil was calculated as a percentage of the dry biomass obtained from the aerial parts of the plant, using the following equation:<disp-formula id="FD1-antibiotics-09-00247"><label>(1)</label><mml:math id="mm1"><mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>O</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mi>O</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi><mml:mi>S</mml:mi></mml:mrow></mml:mfrac><mml:mo>&#x000a0;</mml:mo><mml:mo>&#x000d7;</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula>
Legend: <italic>TO</italic> = oil content in 100 g of biomass; <italic>VO</italic> = volume of oil obtained; <italic>MS</italic> = amount of dry biomass, free of water and humidity; and 100 = conversion factor to percentage [<xref rid="B48-antibiotics-09-00247" ref-type="bibr">48</xref>].</p></sec><sec id="sec4dot4-antibiotics-09-00247"><title>4.4. Phytochemical Analysis</title><p>The chemical composition of the essential oil was determined by gas chromatography coupled to mass spectrometry (CG-EM) using an Agilent 6890 chromatograph (Palo Alto, CA, USA) coupled to an Agilent 5973N mass selection detector. The separation of the constituents was obtained in a capillary column HP-5MS (5%-phenyl-95%-dimethylpolysiloxane, 30 m &#x000d7; 0.25 mm &#x000d7; 0.25 &#x003bc;m) and using helium as the carrier gas (1.0 mL min<sup>&#x02212;1</sup>). The chemical constituents were identified by comparing their mass spectra with the standards reported in the literature [<xref rid="B49-antibiotics-09-00247" ref-type="bibr">49</xref>].</p></sec><sec id="sec4dot5-antibiotics-09-00247"><title>4.5. Bacterial Cultures</title><p>The following multidrug-resistant strains were used in the antibacterial tests: <italic>Pseudomonas aeruginosa</italic> 24, <italic>Staphylococcus aureus</italic> 10 and <italic>Escherichia coli</italic> 06. The origin and resistance profile of these strains is shown in <xref rid="antibiotics-09-00247-t005" ref-type="table">Table 5</xref>.</p><p><italic>S. aureus</italic> strains 1199B and K2068, which carry the NorA and MepA efflux proteins, respectively, were kindly provided by Prof. S. Gibbons (University of London). All strains were initially kept on blood agar (Laboratorios Difco Ltd.a., S&#x000e3;o Paulo, Brazil) and maintained in Heart Infusion Agar (HIA, Difco) medium at 4 &#x000b0;C. Samples were transferred from the solid medium to test tubes containing sterile saline, and turbidity was assessed using a value of 0.5 on the McFarland scale, corresponding to 10<sup>5</sup> CFU.</p></sec><sec id="sec4dot6-antibiotics-09-00247"><title>4.6. Drugs</title><p>Norfloxacin and ciprofloxacin were used in the tests with the 1199B and K2068 strains, respectively. These strains carry the NorA and MepA efflux proteins, respectively, which confer resistance to the corresponding antibiotic. Ethidium bromide was used as an efflux pump inhibitor control. Both antibiotics were dissolved in DMSO and diluted in water, while ethidium bromide was dissolved in water. All drugs were prepared at initial concentrations of 1024 &#x000b5;g/mL and serially diluted in test tubes. Both antibiotics, ethidium bromide and safrole were purchased from SIGMA Chemical Co. (St. Louis, MO, USA).</p></sec><sec id="sec4dot7-antibiotics-09-00247"><title>4.7. Determination of Minimum Inhibitory Concentration (MIC)</title><p>Each inoculum was prepared with 10% Brain Heart Infusion (BHI) at a ratio of 1:9. Next, 100 &#x000b5;L of inoculum in medium was placed in wells on a 96-well plate with 100 &#x000b5;L of the substance at concentrations ranging from 1024 to 8 &#x000b5;g/mL, followed by incubation at 37 &#x000b0;C for 24 h. Positive controls (medium + inoculum) were included in the last wells of the plate [<xref rid="B50-antibiotics-09-00247" ref-type="bibr">50</xref>]. After incubation, 20 &#x000b5;L of sodium resazurin was added to each well, followed by an additional 1 h incubation period at room temperature. A change in the color of the solution, due to the reduction of resazurin, was used as an indicator of bacterial growth [<xref rid="B51-antibiotics-09-00247" ref-type="bibr">51</xref>,<xref rid="B52-antibiotics-09-00247" ref-type="bibr">52</xref>]. The MIC was defined as the lowest concentration capable of inhibiting bacterial growth. All experiments were carried out in triplicate for all bacterial strains.</p></sec><sec id="sec4dot8-antibiotics-09-00247"><title>4.8. Analysis of Antibiotic Resistance Modulation</title><p>To evaluate the ability of the EOOO and safrole to modulate bacterial resistance in the presence of other drugs, the MICs of norfloxacin and ciprofloxacin against resistant strains of <italic>P. aeruginosa</italic>, <italic>E. coli</italic>, and <italic>S. aureus</italic> were determined in the presence or absence of these natural products at concentrations equivalent to their MIC &#x000f7; 8 [<xref rid="B53-antibiotics-09-00247" ref-type="bibr">53</xref>]. The readings were performed as described above.</p></sec><sec id="sec4dot9-antibiotics-09-00247"><title>4.9. Efflux Pump Inhibition Analysis Using an Ethidium Bromide Assay</title><p>In this test, the MIC of ethidium bromide was determined in the presence or absence of sub-inhibitory concentrations of the EOOO and safrole. Briefly, the bacterial inocula were prepared in BHI medium, and the treatments were added at concentrations equivalent to their MIC &#x000f7; 8. Wells on a 96-well plate were filled with 100 &#x000b5;L of the solutions of each treatment and then, ethidium bromide was added to the wells at concentrations ranging from 1024 to 0.5 &#x000b5;g/mL. A reduction in the ethidium bromide MIC was interpreted as EP inhibition [<xref rid="B54-antibiotics-09-00247" ref-type="bibr">54</xref>]. Experimental controls and MIC values for both OEOC and safrole were determined as described above. All tests were performed in triplicate.</p></sec><sec id="sec4dot10-antibiotics-09-00247"><title>4.10. Efflux Pump Inhibition Analysis Using an Antibiotic Resistance Modulation Assay</title><p>Considering that the <italic>S. aureus</italic> strains 1199B and K2068 carry genes encoding efflux proteins associated with antibiotic resistance to norfloxacin and ciprofloxacin, respectively, this protocol was used to evaluate the ability of the EOOO and safrole to modulate bacterial resistance in association with these antibiotics against the corresponding strain. The bacterial inocula were prepared in BHI medium and the treatments were added at concentrations equivalent to their MIC &#x000f7; 8. Wells on a 96-well plate were filled with 100 &#x000b5;L of the solutions of each treatment and then, each antibiotic was added to the wells at concentrations ranging from 1024 to 0.5 &#x000b5;g/mL. A reduction in the MIC of the antibiotic was interpreted as EP inhibition [<xref rid="B54-antibiotics-09-00247" ref-type="bibr">54</xref>]. Experimental controls and MIC values for both EOOO and safrole were determined as described above. All tests were performed in triplicate.</p></sec><sec id="sec4dot11-antibiotics-09-00247"><title>4.11. Molecular Modelling and Docking Studies</title><p>The three-dimensional (3D) structures of the NoRA and MepA proteins were determined using homology models as follows: the three-dimensional structures were predicted using the Protein Homology/Analogy Recognition Engine version 2.0 (Phyre2, available <uri xlink:href="http://www.sbg.bio.ic.ac.uk/phyre2">http://www.sbg.bio.ic.ac.uk/phyre2</uri>) web server, and confirmed using the Iterative Threading Assembly Refinement (I-TASSER, available <uri xlink:href="http://zhanglab.ccmb.med.umich.edu/I-TASSER/">http://zhanglab.ccmb.med.umich.edu/I-TASSER/</uri>) and MODELLER 9.14 servers. The stereochemical quality of the protein structures was checked by the Ramachandran plot using the PROCHECK program [<xref rid="B55-antibiotics-09-00247" ref-type="bibr">55</xref>]. The topographic structure of the pockets and cavities were characterized using the Computed Atlas of Surface Topography of proteins (CASTp, available <uri xlink:href="http://cast.engr.uic.edu">http://cast.engr.uic.edu</uri>) with a standard value of 1.4 &#x000c5; of the radius, and the ligand-binding sites were predicted using the 3DligandSite server [<xref rid="B56-antibiotics-09-00247" ref-type="bibr">56</xref>].</p><p>Docking simulations were carried out with a binding region defined by a 10 &#x000c5; &#x000d7; 10 &#x000c5; &#x000d7; 10 &#x000c5; box set at the centroid of predicted ligand-binding sites. The structures were adjusted using a protein preparation tool provided by the Chimera package (version 1.14, University of California, San Francisco, CA, USA), the 3D structures of ligands were obtained using the corina<sup>&#x000ae;</sup> 3D structure generator (version 4.3, Altamira LLC, Oklahoma city, OK, USA), and minimization of energy was achieved using the UCSF Chimera structure build module [<xref rid="B57-antibiotics-09-00247" ref-type="bibr">57</xref>]. The docking analyses were carried out using the UCSF Chimera and AutoDock Vina software (version 1.1.2., The Scripps Research Institute, La Jolla, CA, USA) based on the iterated local search global optimizer [<xref rid="B58-antibiotics-09-00247" ref-type="bibr">58</xref>]. Proteins and ligands were maintained flexible during the docking process. The selection of flexible residues from proteins was based on the active site at 4.0 &#x000c5; from the co-crystallized ligands. The most favorable binding free energy was represented by clustering the positional Root-mean-square deviation of atomic positions (RMSD) data with no more than 1.0 &#x000c5;. The final docked complexes were analyzed using the Discovery Studio visualizer program version 3.1 (Dassault Syst&#x000e8;mes, San Diego, CA, USA). The binding energy score was used to calculate the inhibition constant (Ki value)-based in an equation by Onawole et al. [<xref rid="B59-antibiotics-09-00247" ref-type="bibr">59</xref>], and the size-independent ligand efficiency (SILE) was measured using the equation described by Nissink, J. W. M. [<xref rid="B60-antibiotics-09-00247" ref-type="bibr">60</xref>].</p></sec><sec id="sec4dot12-antibiotics-09-00247"><title>4.12. Statistical Analysis</title><p>Data are expressed as arithmetic means &#x000b1; standard error of the mean and were analyzed by analysis of variance (ANOVA), followed by Bonferroni&#x02019;s post-test using GraphPad Prism software version 7.00 (available <uri xlink:href="http://www.graphpad.com/scientific-software/prism/">http://www.graphpad.com/scientific-software/prism/</uri>). Statistical significance was considered when <italic>p</italic> &#x0003c; 0.05.</p></sec></sec><sec sec-type="conclusions" id="sec5-antibiotics-09-00247"><title>5. Conclusions</title><p>The essential oil of <italic>Ocotea odorifera</italic> has antibacterial and antibiotic-enhancing activities that are, at least partially, mediated by its major constituent, safrole. Safrole modulates antibiotic resistance in the <italic>S. aureus</italic> SA1119B and K2068 strains, possibly through direct inhibition of the NorA and MepA efflux pumps, respectively.</p><p>In conclusion, <italic>Ocotea odorifera</italic> and safrole present promising antibacterial and antibiotic-enhancing properties, which should be explored in the development of drugs to combat antibacterial resistance, especially in strains bearing genes encoding efflux proteins.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank Regional University of Cariri.</p></ack><notes><title>Author Contributions</title><p>Conceptualization, R.S.A.; methodology, R.S.A., A.C.J.A. and P.R.F.; project administration, I.R.A.M., M.I. and H.D.M.C.; software, I.R.A.M.; conceptualization, E.L.S. and S.R.T.; formal analysis, T.F.M. and V.A.F.; investigation, J.R.F., A.C.A.S. and L.E.S.; writing&#x02014;original draft preparation, W.d.A. and C.D. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors deny the existence of any conflicts of interest regarding this publication.</p></notes><ref-list><title>References</title><ref id="B1-antibiotics-09-00247"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burt</surname><given-names>S.</given-names></name></person-group><article-title>Essential oils: Their antibacterial properties and potential applications in foods: A review</article-title><source>J. Food Microbiol.</source><year>2004</year><volume>94</volume><fpage>223</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2004.03.022</pub-id><?supplied-pmid 15246235?><pub-id pub-id-type="pmid">15246235</pub-id></element-citation></ref><ref id="B2-antibiotics-09-00247"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>U.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Bhatt</surname><given-names>R.P.</given-names></name><name><surname>Manzoor</surname><given-names>N.</given-names></name></person-group><article-title>Antifungal activity of <italic>Coriaria nepalensis</italic> essential oil by disrupting ergosterol biosynthesis and membrane integrity against <italic>Candida</italic></article-title><source>Yeast</source><year>2011</year><volume>28</volume><fpage>611</fpage><lpage>617</lpage><pub-id pub-id-type="doi">10.1002/yea.1890</pub-id><?supplied-pmid 21755533?><pub-id pub-id-type="pmid">21755533</pub-id></element-citation></ref><ref id="B3-antibiotics-09-00247"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez</surname><given-names>S.G.</given-names></name><name><surname>Ramos-L&#x000f3;pez</surname><given-names>M.A.</given-names></name><name><surname>S&#x000e1;nchez-Miranda</surname><given-names>E.</given-names></name><name><surname>Fres&#x000e1;n-Orozco</surname><given-names>M.C.</given-names></name><name><surname>P&#x000e9;rez-Ramos</surname><given-names>J.</given-names></name></person-group><article-title>Antiprotozoa activity of some essential oils</article-title><source>J. Med. Plants Res.</source><year>2012</year><volume>6</volume><fpage>2901</fpage><lpage>2908</lpage><pub-id pub-id-type="doi">10.5897/JMPR11.1572</pub-id></element-citation></ref><ref id="B4-antibiotics-09-00247"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadekuzzaman</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Mizan</surname><given-names>M.F.R.</given-names></name><name><surname>Ha</surname><given-names>S.D.</given-names></name></person-group><article-title>Current and recent advanced strategies for combating biofilms</article-title><source>Comp. Rev. Food Sci. Food Saf.</source><year>2015</year><volume>14</volume><fpage>491</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1111/1541-4337.12144</pub-id></element-citation></ref><ref id="B5-antibiotics-09-00247"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franz</surname><given-names>C.M.</given-names></name></person-group><article-title>Essential oil research: Past, present and future</article-title><source>Flavour. Fragr. J.</source><year>2010</year><volume>25</volume><fpage>112</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1002/ffj.1983</pub-id></element-citation></ref><ref id="B6-antibiotics-09-00247"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakkali</surname><given-names>F.</given-names></name><name><surname>Averbeck</surname><given-names>S.</given-names></name><name><surname>Averbeck</surname><given-names>D.</given-names></name><name><surname>Idaomar</surname><given-names>M.</given-names></name></person-group><article-title>Biological effects of essential oils&#x02014;A review</article-title><source>Food Chem. Toxicol.</source><year>2008</year><volume>46</volume><fpage>446</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2007.09.106</pub-id><pub-id pub-id-type="pmid">17996351</pub-id></element-citation></ref><ref id="B7-antibiotics-09-00247"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubey</surname><given-names>V.S.</given-names></name><name><surname>Bhalla</surname><given-names>R.</given-names></name><name><surname>Luthra</surname><given-names>R.</given-names></name></person-group><article-title>An overview of the non-mevalonate pathway for terpenoid biosynthesis in plants</article-title><source>J. Biosci.</source><year>2003</year><volume>28</volume><fpage>637</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1007/BF02703339</pub-id><pub-id pub-id-type="pmid">14517367</pub-id></element-citation></ref><ref id="B8-antibiotics-09-00247"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peixoto-Neves</surname><given-names>D.</given-names></name><name><surname>Silva-Alves</surname><given-names>K.S.</given-names></name><name><surname>Gomes</surname><given-names>M.D.</given-names></name><name><surname>Lima</surname><given-names>F.C.</given-names></name><name><surname>Lahlou</surname><given-names>S.</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>P.J.</given-names></name><name><surname>Ceccatto</surname><given-names>V.M.</given-names></name><name><surname>Coelho-de-Souza</surname><given-names>A.N.</given-names></name><name><surname>Leal-Cardoso</surname><given-names>J.H.</given-names></name></person-group><article-title>Vasorelaxant effects of the monoterpenic phenol isomers, carvacrol and thymol, on rat isolated aorta</article-title><source>Fundam. Clin. Pharmacol.</source><year>2010</year><volume>24</volume><fpage>341</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1111/j.1472-8206.2009.00768.x</pub-id><pub-id pub-id-type="pmid">19682086</pub-id></element-citation></ref><ref id="B9-antibiotics-09-00247"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>T.G.</given-names></name><name><surname>Laemmle</surname><given-names>J.</given-names></name><name><surname>Rebelo</surname><given-names>R.A.</given-names></name><name><surname>Dalmarco</surname><given-names>E.M.</given-names></name><name><surname>Cruz</surname><given-names>A.B.</given-names></name><name><surname>Schmitd</surname><given-names>A.P.</given-names></name><name><surname>Cruz</surname><given-names>R.C.B.</given-names></name><name><surname>Zeni</surname><given-names>A.L.B.</given-names></name></person-group><article-title>Chemical composition and antimicrobial activity of <italic>Aloysia grat&#x000ed;ssima</italic> (Verbenaceae) leaf essential oil</article-title><source>J. Essent. Oil Res.</source><year>2015</year><volume>2</volume><fpage>125</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1080/10412905.2015.1006737</pub-id></element-citation></ref><ref id="B10-antibiotics-09-00247"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priscilla</surname><given-names>R.F.</given-names></name><name><surname>Ana Carolina</surname><given-names>J.A.</given-names></name><name><surname>Cristina</surname><given-names>R.S.B.</given-names></name><name><surname>D&#x000e9;bora</surname><given-names>F.M.</given-names></name><name><surname>Silva</surname><given-names>A.C.A.</given-names></name><name><surname>Rocha</surname><given-names>J.E.</given-names></name><name><surname>Oliveira-Tintino</surname><given-names>C.D.M.</given-names></name><name><surname>Ribeiro-Filho</surname><given-names>J.</given-names></name><name><surname>Silva</surname><given-names>L.E.</given-names></name><name><surname>Camila Confortin</surname><given-names>C.</given-names></name><etal/></person-group><article-title>GC-MS-FID and potentiation of the antibiotic activity of the essential oil of <italic>Baccharis reticulata</italic> (ruiz &#x00026; pav.) pers. And &#x003b1;-pinene</article-title><source>Ind. Crops Prod.</source><year>2020</year><volume>145</volume><fpage>112106</fpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2020.112106</pub-id></element-citation></ref><ref id="B11-antibiotics-09-00247"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>B.V.</given-names></name><name><surname>Yamada</surname><given-names>L.T.</given-names></name><name><surname>Fagg</surname><given-names>C.W.</given-names></name><name><surname>Brand&#x000e3;o</surname><given-names>M.G.L.</given-names></name></person-group><article-title>Native foods from Brazilian biodiversity as a source of bioactive compounds</article-title><source>Food Res. Int.</source><year>2012</year><volume>48</volume><fpage>170</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2012.03.011</pub-id></element-citation></ref><ref id="B12-antibiotics-09-00247"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolsaris</surname><given-names>A.S.</given-names></name></person-group><article-title>Plants used traditionally to treat malaria in Brazil: The archives of Flora Medicinal</article-title><source>J. Ethnobiol. Ethnomed.</source><year>2007</year><volume>3</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1186/1746-4269-3-18</pub-id><pub-id pub-id-type="pmid">17201916</pub-id></element-citation></ref><ref id="B13-antibiotics-09-00247"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tribess</surname><given-names>B.</given-names></name><name><surname>Pintarelli</surname><given-names>G.M.</given-names></name><name><surname>Bini</surname><given-names>L.A.</given-names></name><name><surname>Camargo</surname><given-names>A.</given-names></name><name><surname>Funez</surname><given-names>L.A.</given-names></name><name><surname>de Gasper</surname><given-names>A.L.</given-names></name><name><surname>Zeni</surname><given-names>A.L.</given-names></name></person-group><article-title>Ethnobotanical study of plants used for therapeutic purposes in the Atlantic Forest region, Southern Brazil</article-title><source>J. Ethnopharmacol.</source><year>2015</year><volume>164</volume><fpage>136</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2015.02.005</pub-id><pub-id pub-id-type="pmid">25680844</pub-id></element-citation></ref><ref id="B14-antibiotics-09-00247"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname><given-names>R.D.</given-names></name><name><surname>Lima</surname><given-names>E.O.</given-names></name></person-group><article-title>Antifungal activity of Brazilian sassafras (<italic>Ocotea odorifera</italic> Vell.) and Rosemary (<italic>Rosmarinus officinalis</italic> L.) essential oils against genus <italic>Candida</italic></article-title><source>Braz. J. Med. Plant.</source><year>2011</year><volume>13</volume><fpage>203</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1590/S1516-05722011000200012</pub-id></element-citation></ref><ref id="B15-antibiotics-09-00247"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junior</surname><given-names>A.R.P.</given-names></name><name><surname>de Carvalho</surname><given-names>R.I.N.</given-names></name><name><surname>Netto</surname><given-names>S.P.</given-names></name><name><surname>Weber</surname><given-names>S.H.</given-names></name><name><surname>de Souza</surname><given-names>E.</given-names></name><name><surname>Furiatti</surname><given-names>R.S.</given-names></name></person-group><article-title>Bioactivity of essential oils of Brazilian implese and eucalyptus against lesser mealworm</article-title><source>Ci&#x000ea;ncia Rural</source><year>2010</year><volume>40</volume><fpage>637</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1590/S0103-84782010005000026</pub-id></element-citation></ref><ref id="B16-antibiotics-09-00247"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riva</surname><given-names>D.</given-names></name><name><surname>Simionatto</surname><given-names>E.L.</given-names></name><name><surname>Junior</surname><given-names>A.W.</given-names></name><name><surname>Salerno</surname><given-names>A.R.</given-names></name><name><surname>Schallenberger</surname><given-names>T.H.</given-names></name></person-group><article-title>Estudo da adapta&#x000e7;&#x000e3;o da esp&#x000e9;cie <italic>Piper hispidinervum</italic> C. DC. (pimenta longa) &#x000e0; regi&#x000e3;o do Vale do Itaja&#x000ed;&#x02013;SC, atrav&#x000e9;s da composi&#x000e7;&#x000e3;o qu&#x000ed;mica do &#x000f3;leo essencial obtido por hidrodestila&#x000e7;&#x000e3;o por micro-ondas e convencional</article-title><source>Act. Amazonica</source><year>2011</year><volume>41</volume><fpage>297</fpage><pub-id pub-id-type="doi">10.1590/S0044-59672011000200016</pub-id></element-citation></ref><ref id="B17-antibiotics-09-00247"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>P.R.R.</given-names></name></person-group><article-title>Safrol e eugenol: Estudo da reatividade qu&#x000ed;mica e uso em s&#x000ed;ntese de produtos naturais biologicamente ativos e seus derivados</article-title><source>Qu&#x000ed;m. Nova</source><year>2000</year><volume>23</volume><fpage>357</fpage><pub-id pub-id-type="doi">10.1590/S0100-40422000000300013</pub-id></element-citation></ref><ref id="B18-antibiotics-09-00247"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khayyat</surname><given-names>A.S.</given-names></name><name><surname>Al-Zahrani</surname><given-names>S.H.</given-names></name></person-group><article-title>Thermal, photosynthesis and antibacterial studies of bioactive safrole derivative as precursor for natural flavor and fragrance</article-title><source>Arab. J. Chem.</source><year>2014</year><volume>7</volume><fpage>800</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1016/j.arabjc.2011.09.014</pub-id></element-citation></ref><ref id="B19-antibiotics-09-00247"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>Q.P.</given-names></name><name><surname>da C&#x000e2;mara</surname><given-names>C.A.G.</given-names></name><name><surname>Ramos</surname><given-names>C.S.</given-names></name><name><surname>Nascimento</surname><given-names>D.C.O.</given-names></name><name><surname>Lima-Filho</surname><given-names>J.V.</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>E.F.</given-names></name></person-group><article-title>Chemical composition, circadian rhythm and antibacterial activity of essential oils of <italic>Piper divaricatum</italic>: A new source of safrole</article-title><source>Qu&#x000ed;m. Nova</source><year>2012</year><volume>35</volume><fpage>1806</fpage><lpage>1808</lpage><pub-id pub-id-type="doi">10.1590/S0100-40422012000900019</pub-id></element-citation></ref><ref id="B20-antibiotics-09-00247"><label>20.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Alterthum</surname><given-names>F.</given-names></name></person-group><source>Microbiologia</source><edition>6th ed.</edition><publisher-name>Atheneu</publisher-name><publisher-loc>S&#x000e3;o Paulo, Brazil</publisher-loc><year>2017</year></element-citation></ref><ref id="B21-antibiotics-09-00247"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loureiro</surname><given-names>R.J.</given-names></name><name><surname>Roque</surname><given-names>F.</given-names></name><name><surname>Rodrigues</surname><given-names>A.T.</given-names></name><name><surname>Herdeiro</surname><given-names>M.T.</given-names></name><name><surname>Ramalheira</surname><given-names>E.</given-names></name></person-group><article-title>O uso de antibi&#x000f3;ticos e as resist&#x000ea;ncias bacterianas: Breves notas sobre a sua evolu&#x000e7;&#x000e3;o</article-title><source>Ver. Port. Ver. Pub.</source><year>2016</year><volume>34</volume><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.rpsp.2015.11.003</pub-id></element-citation></ref><ref id="B22-antibiotics-09-00247"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohl</surname><given-names>T.</given-names></name><name><surname>Pontarolo</surname><given-names>G.H.</given-names></name><name><surname>Pedrassani</surname><given-names>D.</given-names></name></person-group><article-title>Resist&#x000ea;ncia Antimicrobiana De Bact&#x000e9;rias Isoladas De Amostras De Animais Atendidos Em Hospital Veterin&#x000e1;rio</article-title><source>Sa&#x000fa;de. Meio. Ambiente</source><year>2016</year><volume>5</volume><fpage>115</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.24302/sma.v5i2.1197</pub-id></element-citation></ref><ref id="B23-antibiotics-09-00247"><label>23.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tortora</surname><given-names>G.J.</given-names></name><name><surname>CASE</surname><given-names>C.L.</given-names></name><name><surname>Funke</surname><given-names>B.R.</given-names></name></person-group><source>Microbiologia</source><edition>10th ed.</edition><publisher-name>Artmed Editora</publisher-name><publisher-loc>Porto Alegre, Brazil</publisher-loc><year>2012</year></element-citation></ref><ref id="B24-antibiotics-09-00247"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname><given-names>J.M.A.</given-names></name><name><surname>Baylay</surname><given-names>A.J.</given-names></name><name><surname>Ogbolu</surname><given-names>D.O.</given-names></name><name><surname>Piddock</surname><given-names>L.J.</given-names></name></person-group><article-title>Molecular mechanisms of antibiotic resistance</article-title><source>Nat. Ver. Microbiol.</source><year>2015</year><volume>13</volume><fpage>42</fpage><pub-id pub-id-type="doi">10.1038/nrmicro3380</pub-id><?supplied-pmid 25435309?><pub-id pub-id-type="pmid">25435309</pub-id></element-citation></ref><ref id="B25-antibiotics-09-00247"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tintino</surname><given-names>S.R.</given-names></name><name><surname>Oliveira-Tintino</surname><given-names>C.D.M.</given-names></name><name><surname>Campina</surname><given-names>F.F.</given-names></name><name><surname>Limaverde</surname><given-names>P.W.</given-names></name><name><surname>Pereira</surname><given-names>P.S.</given-names></name><name><surname>Siqueira-Junior</surname><given-names>J.P.</given-names></name><name><surname>Coutinho</surname><given-names>H.D.M.</given-names></name><name><surname>Quintans-J&#x000fa;nior</surname><given-names>L.J.</given-names></name><name><surname>da Silva</surname><given-names>T.G.</given-names></name><name><surname>Leal-Balbino</surname><given-names>T.C.</given-names></name><etal/></person-group><article-title>Vitamin K enhances the effect of antibiotics inhibiting the efflux pumps of <italic>Staphylococcus aureus</italic> strains</article-title><source>Med. Chem. Rese.</source><year>2018</year><volume>27</volume><fpage>261</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1007/s00044-017-2063-y</pub-id></element-citation></ref><ref id="B26-antibiotics-09-00247"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahmani</surname><given-names>M.</given-names></name><name><surname>Schmidt</surname><given-names>O.</given-names></name></person-group><article-title>Plant essential oils for environment-friendly protection of wood objects against fungi</article-title><source>Maderas Cienc. Tecnol.</source><year>2018</year><volume>20</volume><fpage>325</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.4067/S0718-221X201800500330</pub-id></element-citation></ref><ref id="B27-antibiotics-09-00247"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza</surname><given-names>L.M.</given-names></name><name><surname>Fonseca</surname><given-names>F.S.A.</given-names></name><name><surname>Silva</surname><given-names>J.C.R.L.</given-names></name><name><surname>Silva</surname><given-names>A.M.</given-names></name><name><surname>Silva</surname><given-names>J.R.</given-names></name><name><surname>Martins</surname><given-names>E.R.</given-names></name></person-group><article-title>Essential oil composition in natural population of Lippia origanoides (Verbenaceae) during dry and rainy seasons</article-title><source>Rev. Biol. Trop.</source><year>2019</year><volume>67</volume><fpage>278</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.15517/rbt.v67i1.31407</pub-id></element-citation></ref><ref id="B28-antibiotics-09-00247"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoefel</surname><given-names>H.H.K.</given-names></name><name><surname>Lautert</surname><given-names>L.</given-names></name></person-group><article-title>Administra&#x000e7;&#x000e3;o endovenosa de antibi&#x000f3;ticos e resist&#x000ea;ncia bacteriana: Responsabilidade da enfermagem</article-title><source>Rev. Eletr&#x000f4;nica. Enferm.</source><year>2006</year><volume>8</volume><fpage>441</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.5216/ree.v8i3.7083</pub-id></element-citation></ref><ref id="B29-antibiotics-09-00247"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al&#x000f3;s</surname><given-names>J.I.</given-names></name></person-group><article-title>Resistencia bacteriana a los antibi&#x000f3;ticos: Ver crisis global</article-title><source>Enferm. Infecc. Microbiol. Clin.</source><year>2015</year><volume>33</volume><fpage>692</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1016/j.eimc.2014.10.004</pub-id><pub-id pub-id-type="pmid">25475657</pub-id></element-citation></ref><ref id="B30-antibiotics-09-00247"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mota</surname><given-names>R.A.</given-names></name><name><surname>da Silva</surname><given-names>K.P.C.</given-names></name><name><surname>de Freitas</surname><given-names>M.F.L.</given-names></name><name><surname>Porto</surname><given-names>W.J.N.</given-names></name><name><surname>da Silva</surname><given-names>L.B.G.</given-names></name></person-group><article-title>Utiliza&#x000e7;&#x000e3;o indiscriminada de anmicrobianos e sua contribui&#x000e7;&#x000e3;o a 14imple14se14st&#x000ea;ncia bacteriana</article-title><source>Braz. J. Vet. Res. Anim. Sci.</source><year>2005</year><volume>42</volume><fpage>465</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.11606/issn.1678-4456.bjvras.2005.26406</pub-id></element-citation></ref><ref id="B31-antibiotics-09-00247"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mossi</surname><given-names>J.A.</given-names></name><name><surname>Zanella</surname><given-names>C.A.</given-names></name><name><surname>Kubiak</surname><given-names>G.B.</given-names></name><name><surname>Lerin</surname><given-names>L.A.</given-names></name><name><surname>Cansian</surname><given-names>R.L.</given-names></name><name><surname>Frandoloso</surname><given-names>F.S.</given-names></name><name><surname>Pr&#x000e1;</surname><given-names>V.D.</given-names></name><name><surname>Mazutti</surname><given-names>M.A.</given-names></name><name><surname>Costa</surname><given-names>J.A.V.</given-names></name><name><surname>Treichel</surname><given-names>H.</given-names></name></person-group><article-title>Essential oil of Ocotea odorifera: An alternative against Sitophilus zeamais</article-title><source>Renew. Agric. Food Syst.</source><year>2014</year><volume>29</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1017/S1742170513000045</pub-id></element-citation></ref><ref id="B32-antibiotics-09-00247"><label>32.</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Lorenzi</surname><given-names>H.</given-names></name><name><surname>Matos</surname><given-names>F.J.A.</given-names></name></person-group><article-title>Plantas medicinais no Brasil: Nativas e ex&#x000f3;ticas</article-title><source>Inst. Plant.</source><year>2002</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.sidalc.net/cgibin/wxis.exe/?IsisScript=LIBROS.xis&#x00026;method=post&#x00026;formato=2&#x00026;cantidad=1&#x00026;expresion=mfn=008440">http://www.sidalc.net/cgibin/wxis.exe/?IsisScript=LIBROS.xis&#x00026;method=post&#x00026;formato=2&#x00026;cantidad=1&#x00026;expresion=mfn=008440</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-05-10">(accessed on 10 May 2020)</date-in-citation></element-citation></ref><ref id="B33-antibiotics-09-00247"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>D.C.</given-names></name><name><surname>Blank</surname><given-names>A.F.</given-names></name><name><surname>Nizio</surname><given-names>D.A.C.</given-names></name><name><surname>Sampaio</surname><given-names>T.S.</given-names></name><name><surname>Nogueira</surname><given-names>P.C.L.</given-names></name><name><surname>Arrigoni-blank</surname><given-names>M.F.</given-names></name></person-group><article-title>Chemical diversity of essential oils from native populations of Eplingiella implese</article-title><source>Crop Breed. Appl. Biot.</source><year>2018</year><volume>18</volume><fpage>205</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1590/1984-70332018v18n2n29</pub-id></element-citation></ref><ref id="B34-antibiotics-09-00247"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazzaro</surname><given-names>F.</given-names></name><name><surname>Frantianni</surname><given-names>F.</given-names></name><name><surname>de Martino</surname><given-names>L.</given-names></name><name><surname>Coppola</surname><given-names>R.</given-names></name><name><surname>de Feo</surname><given-names>V.</given-names></name></person-group><article-title>Effect of Essential Oils on Pathogenic Bacteria</article-title><source>Pharmaceuticals</source><year>2013</year><volume>6</volume><fpage>1451</fpage><lpage>1474</lpage><pub-id pub-id-type="doi">10.3390/ph6121451</pub-id><?supplied-pmid 24287491?><pub-id pub-id-type="pmid">24287491</pub-id></element-citation></ref><ref id="B35-antibiotics-09-00247"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betim</surname><given-names>F.C.M.</given-names></name><name><surname>Souza</surname><given-names>A.M.</given-names></name><name><surname>Szabo</surname><given-names>E.M.</given-names></name><name><surname>Zanin</surname><given-names>S.M.W.</given-names></name><name><surname>Miguel</surname><given-names>O.G.</given-names></name><name><surname>Miguel</surname><given-names>M.D.</given-names></name><name><surname>Dias</surname><given-names>J.F.G.</given-names></name></person-group><article-title><italic>Ocotea nutans</italic> (Nees) Mez (LAURACEAE): Chemical composition, antioxidante capacity and biological properties of essential oil</article-title><source>Braz. J. Pharm. Sci.</source><year>2019</year><volume>55</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1590/s2175-97902019000118284</pub-id></element-citation></ref><ref id="B36-antibiotics-09-00247"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damascemo</surname><given-names>C.S.B.</given-names></name><name><surname>de Oliveira</surname><given-names>L.F.</given-names></name><name><surname>Szabo</surname><given-names>E.M.</given-names></name><name><surname>Souza</surname><given-names>A.M.</given-names></name><name><surname>Dias</surname><given-names>J.F.G.</given-names></name><name><surname>Miguel</surname><given-names>M.D.</given-names></name><name><surname>Miguel</surname><given-names>O.G.</given-names></name></person-group><article-title>Chemical composition, antioxidant and biological activity of <italic>Ocotea odor&#x000ed;fera</italic> Vattimo-Gil (LAURACEAE) essential oil</article-title><source>Braz. J. Pharm. Sci.</source><year>2017</year><volume>53</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1590/s2175-902017000417298</pub-id></element-citation></ref><ref id="B37-antibiotics-09-00247"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cansian</surname><given-names>R.L.</given-names></name><name><surname>Mossi</surname><given-names>A.J.</given-names></name><name><surname>Paroul</surname><given-names>N.</given-names></name><name><surname>Toniazzo</surname><given-names>G.</given-names></name><name><surname>Zboralski</surname><given-names>F.</given-names></name><name><surname>Prichoa</surname><given-names>F.C.</given-names></name><name><surname>Kubiak</surname><given-names>G.B.</given-names></name><name><surname>Lerin</surname><given-names>L.A.</given-names></name></person-group><article-title>Atividade antioxidante e antimicrobiana de extratos de canela-sassafr&#x000e1;s (<italic>Ocotea odor&#x000ed;fera</italic> (VELL) Rowher)</article-title><source>Perspect. Erechim.</source><year>2010</year><volume>34</volume><fpage>123</fpage><lpage>133</lpage></element-citation></ref><ref id="B38-antibiotics-09-00247"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>P.S.</given-names></name><name><surname>Lima</surname><given-names>M.D.C.A.</given-names></name><name><surname>Neto</surname><given-names>P.P.M.</given-names></name><name><surname>Oliveira-Tintino</surname><given-names>C.D.M.</given-names></name><name><surname>Tintino</surname><given-names>S.R.</given-names></name><name><surname>Menezes</surname><given-names>I.R.A.</given-names></name><name><surname>de Oliveira</surname><given-names>J.F.</given-names></name><name><surname>Marchand</surname><given-names>P.</given-names></name><name><surname>Coutinho</surname><given-names>H.D.M.</given-names></name><name><surname>Rodrigues</surname><given-names>M.D.D.</given-names></name><etal/></person-group><article-title>Thiazolidinedione and thiazole derivatives potentiate norfloxacin activity against NorA efflux pump over expression in Staphylococcus aureus 1199B strains</article-title><source>Bioorg. Med. Chem.</source><year>2019</year><volume>27</volume><fpage>3797</fpage><lpage>3804</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2019.07.006</pub-id><?supplied-pmid 31320212?><pub-id pub-id-type="pmid">31320212</pub-id></element-citation></ref><ref id="B39-antibiotics-09-00247"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tintino</surname><given-names>S.R.</given-names></name><name><surname>Oliveira-Tintino</surname><given-names>C.D.</given-names></name><name><surname>Campina</surname><given-names>F.F.</given-names></name><name><surname>Silva</surname><given-names>R.L.</given-names></name><name><surname>Costa</surname><given-names>M.do.S.</given-names></name><name><surname>Menezes</surname><given-names>I.R.</given-names></name><name><surname>Calixto-J&#x000fa;nior</surname><given-names>J.T.</given-names></name><name><surname>Siqueira-Junior</surname><given-names>J.P.</given-names></name><name><surname>Coutinho</surname><given-names>H.D.M.</given-names></name><name><surname>Leal-Balbino</surname><given-names>T.C.</given-names></name><etal/></person-group><article-title>Evaluation of the tannic acid inhibitory effect against the NorA efflux pump of <italic>Staphylococcus aureus</italic></article-title><source>Microb. Pathog.</source><year>2016</year><volume>97</volume><fpage>9</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2016.04.003</pub-id><pub-id pub-id-type="pmid">27057677</pub-id></element-citation></ref><ref id="B40-antibiotics-09-00247"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira-Tintino</surname><given-names>C.D.M.</given-names></name><name><surname>Tintino</surname><given-names>S.R.</given-names></name><name><surname>Limaverde</surname><given-names>P.W.</given-names></name><name><surname>Figueredo</surname><given-names>F.G.</given-names></name><name><surname>Campina</surname><given-names>F.F.</given-names></name><name><surname>da Cunha</surname><given-names>F.A.B.</given-names></name><name><surname>da Costa</surname><given-names>R.H.S.</given-names></name><name><surname>Pereira</surname><given-names>P.S.</given-names></name><name><surname>Lima</surname><given-names>L.F.</given-names></name><name><surname>de Matos</surname><given-names>Y.M.L.S.</given-names></name><etal/></person-group><article-title>Inhibition of the essential oil from Chenopodium ambrosioides L. and &#x003b1;-terpinene on the NorA efflux-pump of <italic>Staphylococcus aureus</italic></article-title><source>Food Chem.</source><year>2018</year><volume>226</volume><fpage>72</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2018.04.040</pub-id></element-citation></ref><ref id="B41-antibiotics-09-00247"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tintino</surname><given-names>S.R.</given-names></name><name><surname>Oliveira-Tintino</surname><given-names>C.D.M.</given-names></name><name><surname>Campina</surname><given-names>F.F.</given-names></name><name><surname>Costa</surname><given-names>M.D.S.</given-names></name><name><surname>Menezes</surname><given-names>I.R.A.</given-names></name><name><surname>Matos</surname><given-names>Y.M.L.S.</given-names></name><name><surname>Calixto-J&#x000fa;nior</surname><given-names>J.T.</given-names></name><name><surname>Pereira</surname><given-names>P.S.</given-names></name><name><surname>Siqueira-Junior</surname><given-names>J.P.</given-names></name><name><surname>Leal-Balbino</surname><given-names>T.C.</given-names></name><etal/></person-group><article-title>Tannic acid affects the phenotype of <italic>Staphylococcus aureus</italic> resistant to tetracycline and erythromycin by inhibition of efflux pumps</article-title><source>Bioorg. Chem.</source><year>2017</year><volume>74</volume><fpage>197</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2017.08.004</pub-id><pub-id pub-id-type="pmid">28841421</pub-id></element-citation></ref><ref id="B42-antibiotics-09-00247"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>S.S.</given-names></name><name><surname>Falc&#x000e3;o</surname><given-names>C.</given-names></name><name><surname>Viveiros</surname><given-names>H.</given-names></name><name><surname>Machado</surname><given-names>D.</given-names></name><name><surname>Martins</surname><given-names>H.</given-names></name><name><surname>Melo</surname><given-names>C.J.</given-names></name><name><surname>Amaral</surname><given-names>G.</given-names></name></person-group><article-title>Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of <italic>Staphylococcus aureus</italic></article-title><source>BMC Microbiol.</source><year>2011</year><volume>11</volume><elocation-id>241</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-11-241</pub-id><pub-id pub-id-type="pmid">22032541</pub-id></element-citation></ref><ref id="B43-antibiotics-09-00247"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindler</surname><given-names>B.D.</given-names></name><name><surname>Jacinto</surname><given-names>P.</given-names></name><name><surname>Kaatz</surname><given-names>G.W.</given-names></name></person-group><article-title>Inhibition of drug efflux pumps in <italic>Staphylococcus aureus</italic>: Current status of potentiating existing antibiotics</article-title><source>Future. Microbiol.</source><year>2013</year><volume>8</volume><fpage>491</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.2217/fmb.13.16</pub-id><pub-id pub-id-type="pmid">23534361</pub-id></element-citation></ref><ref id="B44-antibiotics-09-00247"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaatz</surname><given-names>G.W.</given-names></name></person-group><article-title>Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus</article-title><source>Antimicrob. Agents Chemother.</source><year>2003</year><volume>47</volume><fpage>719</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1128/AAC.47.2.719-726.2003</pub-id><?supplied-pmid 12543683?><pub-id pub-id-type="pmid">12543683</pub-id></element-citation></ref><ref id="B45-antibiotics-09-00247"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabatini</surname><given-names>S.</given-names></name><name><surname>Kaatz</surname><given-names>G.W.</given-names></name><name><surname>Rossolini</surname><given-names>G.M.</given-names></name><name><surname>Brandini</surname><given-names>D.</given-names></name><name><surname>Fravolini</surname><given-names>A.</given-names></name></person-group><article-title>From phenothiazine to 3-phenyl-1, 4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump</article-title><source>J. Med. Chem.</source><year>2008</year><volume>51</volume><fpage>4321</fpage><lpage>4330</lpage><pub-id pub-id-type="doi">10.1021/jm701623q</pub-id><?supplied-pmid 18578473?><pub-id pub-id-type="pmid">18578473</pub-id></element-citation></ref><ref id="B46-antibiotics-09-00247"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alem&#x000e3;o</surname><given-names>N.</given-names></name><name><surname>Wei</surname><given-names>P.</given-names></name><name><surname>Kaatz</surname><given-names>G.W.</given-names></name><name><surname>Kerns</surname><given-names>R.J.</given-names></name></person-group><article-title>Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps</article-title><source>Eur. J. Med. Chem.</source><year>2008</year><volume>43</volume><fpage>2453</fpage><lpage>2463</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2008.01.042</pub-id><pub-id pub-id-type="pmid">18358571</pub-id></element-citation></ref><ref id="B47-antibiotics-09-00247"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasicky</surname><given-names>R.</given-names></name></person-group><article-title>Uma modifica&#x000e7;&#x000e3;o do aparelho de clevenger para extra&#x000e7;&#x000e3;o de &#x000f3;leos essenciais</article-title><source>Rev. Fac. Farm&#x000e1;cia Bioqu&#x000ed;mica</source><year>1963</year><volume>1</volume><fpage>77</fpage><lpage>81</lpage></element-citation></ref><ref id="B48-antibiotics-09-00247"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girard</surname><given-names>E.A.</given-names></name><name><surname>Koehler</surname><given-names>H.S.</given-names></name><name><surname>Netto</surname><given-names>S.P.</given-names></name></person-group><article-title>Volume, biomassa e rendimento de &#x000f3;leos essenciais do craveiro (pimenta pseudocaryophyllus (gomes) landrum</article-title><source>Ver. Acad. Curitiba</source><year>2007</year><volume>5</volume><fpage>147</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.7213/cienciaanimal.v5i2.9744</pub-id></element-citation></ref><ref id="B49-antibiotics-09-00247"><label>49.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>R.P.</given-names></name></person-group><source>Identification of Essential Oil Components by Gas Chromatography/mass Spectroscopy</source><publisher-name>Allured Publishing Corporation</publisher-name><publisher-loc>Carol Stream, IL, USA</publisher-loc><year>2007</year></element-citation></ref><ref id="B50-antibiotics-09-00247"><label>50.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>National Committee for Clinical Laboratory Standards (NCCLS)</collab></person-group><source>Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically</source><edition>6th ed.</edition><publisher-name>NCCLS</publisher-name><publisher-loc>Pennsylvania, PA, USA</publisher-loc><year>2003</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://clsi.org/media/1632/m07a10_sample.pdf">https://clsi.org/media/1632/m07a10_sample.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-01-10">(accessed on 10 January 2020)</date-in-citation></element-citation></ref><ref id="B51-antibiotics-09-00247"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>C.M.</given-names></name><name><surname>Markham</surname><given-names>J.L.</given-names></name></person-group><article-title>A new method for determining the minimum inhibitory concentration of essential oils</article-title><source>J. Appl. Microb.</source><year>1998</year><volume>84</volume><fpage>538</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2672.1998.00379.x</pub-id></element-citation></ref><ref id="B52-antibiotics-09-00247"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palomino</surname><given-names>J.C.</given-names></name><name><surname>Martin</surname><given-names>A.</given-names></name><name><surname>Camacho</surname><given-names>H.</given-names></name><name><surname>Guerra</surname><given-names>H.</given-names></name><name><surname>Swings</surname><given-names>J.</given-names></name><name><surname>Portaels</surname><given-names>F.</given-names></name></person-group><article-title>Resazurin microtiter assay plate: Imple and unexpensive method for detection of drug resistance in Mycobacterium tuberculosis</article-title><source>Antimicrob. Agents Chemother.</source><year>2002</year><volume>46</volume><fpage>2720</fpage><lpage>2722</lpage><pub-id pub-id-type="doi">10.1128/AAC.46.8.2720-2722.2002</pub-id><pub-id pub-id-type="pmid">12121966</pub-id></element-citation></ref><ref id="B53-antibiotics-09-00247"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coutinho</surname><given-names>H.D.M.</given-names></name><name><surname>Costa</surname><given-names>J.G.</given-names></name><name><surname>Lima</surname><given-names>E.O.</given-names></name><name><surname>Falc&#x000e3;o-Silva</surname><given-names>V.S.</given-names></name><name><surname>Siqueira-J&#x000fa;nior</surname><given-names>J.P.</given-names></name></person-group><article-title>Enhancement of the antibiotic activity against a multiresistant Escherichia coli by Mentha arvensis L. and chlorpromazine</article-title><source>Chemotherapy</source><year>2008</year><volume>54</volume><fpage>328</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1159/000151267</pub-id><pub-id pub-id-type="pmid">18698137</pub-id></element-citation></ref><ref id="B54-antibiotics-09-00247"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tintino</surname><given-names>S.R.</given-names></name><name><surname>Oliveira-Tintino</surname><given-names>C.D.</given-names></name><name><surname>Campina</surname><given-names>F.F.</given-names></name><name><surname>Costa</surname><given-names>M.S.</given-names></name><name><surname>Cruz</surname><given-names>R.P.</given-names></name><name><surname>Pereira</surname><given-names>R.L.</given-names></name><name><surname>Andrade</surname><given-names>J.C.</given-names></name><name><surname>Sousa</surname><given-names>E.O.</given-names></name><name><surname>Siqueira-Junior</surname><given-names>J.P.</given-names></name><name><surname>Coutinho</surname><given-names>H.D.M.</given-names></name><etal/></person-group><article-title>Cholesterol and ergosterol affect the activity of Staphylococcus aureus antibiotic efflux pumps</article-title><source>Microb. Pathog.</source><year>2017</year><volume>104</volume><fpage>133</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2017.01.019</pub-id><pub-id pub-id-type="pmid">28088472</pub-id></element-citation></ref><ref id="B55-antibiotics-09-00247"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laskowski</surname><given-names>R.A.</given-names></name><name><surname>MacArthur</surname><given-names>M.W.</given-names></name><name><surname>Moss</surname><given-names>D.S.</given-names></name><name><surname>Thornton</surname><given-names>J.M.</given-names></name></person-group><article-title>PROCHECK&#x02013;a program to check the stereochemical quality of protein structures</article-title><source>J. App. Cryst.</source><year>1993</year><volume>26</volume><fpage>283</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1107/S0021889892009944</pub-id></element-citation></ref><ref id="B56-antibiotics-09-00247"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wass</surname><given-names>M.N.</given-names></name><name><surname>Kelley</surname><given-names>L.A.</given-names></name><name><surname>Sternberg</surname><given-names>M.J.</given-names></name></person-group><article-title>3DLigandSite: Predicting ligand-binding sites using similar structures</article-title><source>Nucleic. Acids Res.</source><year>2010</year><volume>38</volume><fpage>W469</fpage><lpage>W473</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq406</pub-id><?supplied-pmid 20513649?><pub-id pub-id-type="pmid">20513649</pub-id></element-citation></ref><ref id="B57-antibiotics-09-00247"><label>57.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>3D Structure Generator CORINA Classic</collab></person-group><article-title>3D Structure Generator CORINA Classic. N&#x000fc;rnberg: Molecular Networks GmbH</article-title><year>2019</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.mn-am.com">http://www.mn-am.com</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-05-10">(accessed on 10 May 2020)</date-in-citation></element-citation></ref><ref id="B58-antibiotics-09-00247"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trott</surname><given-names>A.J.</given-names></name></person-group><article-title>Olson, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading</article-title><source>J. Comput. Chem.</source><year>2010</year><volume>31</volume><fpage>455</fpage><lpage>461</lpage><?supplied-pmid 19499576?><pub-id pub-id-type="pmid">19499576</pub-id></element-citation></ref><ref id="B59-antibiotics-09-00247"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onawole</surname><given-names>A.T.</given-names></name><name><surname>Kolapo</surname><given-names>T.U.</given-names></name><name><surname>Sulaiman</surname><given-names>K.O.</given-names></name><name><surname>Adegoke</surname><given-names>R.O.</given-names></name></person-group><article-title>Structure based virtual screening of the Ebola virus trimeric glycoprotein using consensus scoring</article-title><source>Comput. Biol. chem.</source><year>2018</year><volume>72</volume><fpage>170</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/j.compbiolchem.2017.11.006</pub-id><?supplied-pmid 29361403?><pub-id pub-id-type="pmid">29361403</pub-id></element-citation></ref><ref id="B60-antibiotics-09-00247"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nissink</surname><given-names>J.W.M.</given-names></name></person-group><article-title>Simple size-independent measure of ligand efficiency</article-title><source>J. Chem. Inform. Model.</source><year>2009</year><volume>49</volume><fpage>1617</fpage><lpage>1622</lpage><pub-id pub-id-type="doi">10.1021/ci900094m</pub-id><?supplied-pmid 19438171?><pub-id pub-id-type="pmid">19438171</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="antibiotics-09-00247-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Minimum Inhibitory Concentration (MIC) of norfloxacin alone or in the presence of <italic>O. odor&#x000ed;fera</italic> or safrole against the <italic>multiresistant strains E. coli</italic> 06, <italic>S. aureus</italic> 10 and <italic>P. aeruginosa</italic> 24. **** <italic>p</italic> &#x0003c; 0.0001 indicates significant differences between groups. Statistical significance was determined by one-way ANOVA and Bonferroni&#x02019;s post-hoc test.</p></caption><graphic xlink:href="antibiotics-09-00247-g001"/></fig><fig id="antibiotics-09-00247-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Minimum Inhibitory Concentration (MIC) of ethidium bromide alone or associated with safrole or chlorpromazine (control) against <italic>S. aureus</italic> 1199B and K2068 strains. **** <italic>p</italic> &#x0003c; 0.0001 indicates significant differences between groups. Statistical significance was determined by one-way ANOVA and Bonferroni&#x02019;s post-hoc test.</p></caption><graphic xlink:href="antibiotics-09-00247-g002"/></fig><fig id="antibiotics-09-00247-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Minimum Inhibitory Concentration (MIC) by safrole in association with norfloxacin or ciprofloxacin against <italic>S. aureus</italic> 1199B and K2068 strains. **** <italic>p</italic> &#x0003c; 0.0001 indicates significant differences between groups. Statistical significance was determined by one-way ANOVA and Bonferroni&#x02019;s post-hoc test.</p></caption><graphic xlink:href="antibiotics-09-00247-g003"/></fig><fig id="antibiotics-09-00247-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Chemical structures of Safrol (<bold>A</bold>) and Chlorpromazine (<bold>B</bold>). Binding poses of best stability of safrole and chlorpromazine with the NorA (<bold>C</bold>) and MepA (<bold>D</bold>). Interaction maps showing the binding of chlorpromazine to amino acid residues in the NorA (<bold>E</bold>) and MepA (<bold>F</bold>) binding sites. Interaction maps showing the binding of safrole to amino acid residues in the NorA (<bold>G</bold>) and MepA (<bold>H</bold>) binding sites.</p></caption><graphic xlink:href="antibiotics-09-00247-g004a"/><graphic xlink:href="antibiotics-09-00247-g004b"/></fig><fig id="antibiotics-09-00247-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Sample of the plant <italic>Ocotea odor&#x000ed;fera.</italic></p></caption><graphic xlink:href="antibiotics-09-00247-g005"/></fig><table-wrap id="antibiotics-09-00247-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">antibiotics-09-00247-t001_Table 1</object-id><label>Table 1</label><caption><p>GC-MS profile of the essential oil of <italic>Ocotea odor&#x000ed;fera</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RI</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">936</td><td align="center" valign="middle" rowspan="1" colspan="1">Alpha-pinene</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">951</td><td align="center" valign="middle" rowspan="1" colspan="1">Camphene</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">978</td><td align="center" valign="middle" rowspan="1" colspan="1">Beta-pinene</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1005</td><td align="center" valign="middle" rowspan="1" colspan="1">Alpha-felandrene</td><td align="center" valign="middle" rowspan="1" colspan="1">1.9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1026</td><td align="center" valign="middle" rowspan="1" colspan="1">Ortho-cymene</td><td align="center" valign="middle" rowspan="1" colspan="1">3.0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1033</td><td align="center" valign="middle" rowspan="1" colspan="1">1,8-Cineole</td><td align="center" valign="middle" rowspan="1" colspan="1">0.9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1145</td><td align="center" valign="middle" rowspan="1" colspan="1">Camphor</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1189</td><td align="center" valign="middle" rowspan="1" colspan="1">Alfa-terpineol</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1292</td><td align="center" valign="middle" rowspan="1" colspan="1">Safrole</td><td align="center" valign="middle" rowspan="1" colspan="1">77.9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1356</td><td align="center" valign="middle" rowspan="1" colspan="1">Eugenol</td><td align="center" valign="middle" rowspan="1" colspan="1">0.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1414</td><td align="center" valign="middle" rowspan="1" colspan="1">(<italic>E</italic>)-caryophyllene</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1476</td><td align="center" valign="middle" rowspan="1" colspan="1">Gama-muurolene</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1487</td><td align="center" valign="middle" rowspan="1" colspan="1">Delta-selinene</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1491</td><td align="center" valign="middle" rowspan="1" colspan="1">Bicyclogemacrene</td><td align="center" valign="middle" rowspan="1" colspan="1">1.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1572</td><td align="center" valign="middle" rowspan="1" colspan="1">Spathulenol</td><td align="center" valign="middle" rowspan="1" colspan="1">4.0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1648</td><td align="center" valign="middle" rowspan="1" colspan="1">11-selinen-4-alpha-ol</td><td align="center" valign="middle" rowspan="1" colspan="1">1.2</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Total composition identified</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>93.1</bold>
</td></tr></tbody></table><table-wrap-foot><fn><p>Legend: RI = Retention Index.</p></fn></table-wrap-foot></table-wrap><table-wrap id="antibiotics-09-00247-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">antibiotics-09-00247-t002_Table 2</object-id><label>Table 2</label><caption><p>Minimum Inhibitory Concentrations (MICs) of the EOOO and safrole.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bacterial Strain</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EOOO MIC(&#x003bc;g/mL)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SafroleMIC (&#x003bc;g/mL)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. aureus</italic> 10</td><td align="center" valign="middle" rowspan="1" colspan="1">512</td><td align="center" valign="middle" rowspan="1" colspan="1">512</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>E. coli</italic> 06</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;1024</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02265;1024</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>P. aeruginosa</italic> 24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02265;1024</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02265;1024</td></tr></tbody></table></table-wrap><table-wrap id="antibiotics-09-00247-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">antibiotics-09-00247-t003_Table 3</object-id><label>Table 3</label><caption><p>Molecular docking and analysis of interactions between EP inhibitors and NorA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MIC (&#x000b5;g/mL)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IE (Kcal/mol)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ki (&#x000b5;M)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SILE</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ethidium Bromide</td><td align="center" valign="middle" rowspan="1" colspan="1">128</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.8</td><td align="center" valign="middle" rowspan="1" colspan="1">1.95</td><td align="center" valign="middle" rowspan="1" colspan="1">0.74</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Chlorpromazine</td><td align="center" valign="middle" rowspan="1" colspan="1">64</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.4</td><td align="center" valign="middle" rowspan="1" colspan="1">20.64</td><td align="center" valign="middle" rowspan="1" colspan="1">7.86</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Safrole</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80.63</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;5.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.95</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.72</td></tr></tbody></table><table-wrap-foot><fn><p>Legends: MIC = minimum inhibitory concentration; IE = interaction energy; Ki = inhibition constant; SILE = size independent ligand efficiency.</p></fn></table-wrap-foot></table-wrap><table-wrap id="antibiotics-09-00247-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">antibiotics-09-00247-t004_Table 4</object-id><label>Table 4</label><caption><p>Molecular docking and analysis of interactions between EP inhibitors and MepA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MIC (&#x000b5;g/mL)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IE (Kcal/mol)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ki (&#x000b5;M)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SILE</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ethidium Bromide</td><td align="center" valign="middle" rowspan="1" colspan="1">128</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.6</td><td align="center" valign="middle" rowspan="1" colspan="1">0.51</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Chlorpromazine</td><td align="center" valign="middle" rowspan="1" colspan="1">85.33</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.9</td><td align="center" valign="middle" rowspan="1" colspan="1">8.88</td><td align="center" valign="middle" rowspan="1" colspan="1">3.47</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Safrole</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;6.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.19</td></tr></tbody></table><table-wrap-foot><fn><p>Legends: MIC = minimum inhibitory concentration; IE = interaction energy; Ki = inhibition constant; SILE = size independent ligand efficiency.</p></fn></table-wrap-foot></table-wrap><table-wrap id="antibiotics-09-00247-t005" orientation="portrait" position="float"><object-id pub-id-type="pii">antibiotics-09-00247-t005_Table 5</object-id><label>Table 5</label><caption><p>Origin and antibiotic resistance profile of the strains.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bacterial Strain</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Origin</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Resistance Profile</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. aureus</italic> 10</td><td align="center" valign="middle" rowspan="1" colspan="1">Rectum swab</td><td align="center" valign="middle" rowspan="1" colspan="1">Amc, Amox, Amp, Asb, Azi, Cefa Cef, Cf, Cip, Cla, Clin, Ery, Lev, Mox, Oxa, Pen</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>E. coli</italic> 06</td><td align="center" valign="middle" rowspan="1" colspan="1">Urine</td><td align="center" valign="middle" rowspan="1" colspan="1">Asb, Cefa, Cef, Cfo, Cpm, Ctx</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>P. aeruginosa</italic> 24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nasal discharge </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ami, Cip, Ctz, Imi, Lev, Mer, Ptz</td></tr></tbody></table><table-wrap-foot><fn><p>Legend: Amc&#x02014;Amoxicillin + Clavulanic Acid, Ami&#x02014;Amikacin, Amox&#x02014;Amoxicillin, Amp Ampicillin, Asb&#x02014;Ampicillin + Sulbactam, Azi&#x02014;Azithromycin, Cefa&#x02014;Cefadroxil; Cef&#x02014;Cephalexin, Cfo&#x02014;Cefoxitin, Cip&#x02014;Ciprofloxacin, Cla&#x02014;Clarithromycin, Clin&#x02014;Clindamycin, Cpm&#x02014;Cefepime, Ctx&#x02014;Ceftriaxone, Ctz&#x02014;Ceftazidime, Ery&#x02014;Erythromycin, Imi&#x02014;Imipenem, Lev&#x02014;Levofloxacin, Mer&#x02014;Meropenem, Mox&#x02014;Moxifloxacin, Oxa&#x02014;Oxacillin, Pen&#x02014;Penicillin and Ptz&#x02014;Piperacillin.</p></fn></table-wrap-foot></table-wrap></floats-group></article>